Assets
| Type | Time | Amount | Unit |
|---|---|---|---|
| ifrs-full:Assets | 2015-06-30 | 12841000 | u5 |
| ifrs-full:Assets | 2015-06-30 | 95544798 | u5 |
| ifrs-full:Assets | 2014-06-30 | 35563869 | u5 |
| ifrs-full:Assets | 2015-06-30 | 65921000 | u5 |
| ifrs-full:Assets | 2015-06-30 | 60757000 | u5 |
Revenue
| Type | Start date | End date | Amount | Unit |
|---|
XML
See the xml submitted here:
XML: http://regnskaber.virk.dk/55366223/ZG9rdW1lbnRsYWdlcjovLzAzL2I0LzFmLzk2LzJmLzdiMzgtNDU0Ny05N2I2LTNkMWVkMjBiMDNjOA.xml
Separator
The full data:
<?xml version="1.0" encoding="UTF-8"?><xbrl xmlns="http://www.xbrl.org/2003/instance" xmlns:g="http://xbrl.dcca.dk/sob" xmlns:b="http://xbrl.dcca.dk/entryBalanceSheetAccountFormIncomeStatementByNature" xmlns:h="http://xbrl.dcca.dk/mrv" xmlns:f="http://xbrl.dcca.dk/arr" xmlns:d="http://xbrl.dcca.dk/cmn" xmlns:e="http://xbrl.dcca.dk/fsa" xmlns:c="http://xbrl.dcca.dk/gsd" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://xbrl.dcca.dk/entryBalanceSheetAccountFormIncomeStatementByNature http://archprod.service.eogs.dk/taxonomy/20140701/entryDanishGAAPBalanceSheetAccountFormIncomeStatementByNatureIncludingManagementsReviewStatisticsAndTax20140701.xsd"><link:schemaRef xlink:type="simple" xlink:href="http://archprod.service.eogs.dk/taxonomy/20140701/entryDanishGAAPBalanceSheetAccountFormIncomeStatementByNatureIncludingManagementsReviewStatisticsAndTax20140701.xsd"/><c:InformationOnTypeOfSubmittedReport contextRef="c1">Ã
rsrapport</c:InformationOnTypeOfSubmittedReport><c:IdentificationNumberCvrOfSubmittingEnterprise contextRef="c1">14119299</c:IdentificationNumberCvrOfSubmittingEnterprise><c:NameOfSubmittingEnterprise contextRef="c1">PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab</c:NameOfSubmittingEnterprise><c:AddressOfSubmittingEnterpriseStreetAndNumber contextRef="c1">Hovedvejen, 56</c:AddressOfSubmittingEnterpriseStreetAndNumber><c:AddressOfSubmittingEnterprisePostcodeAndTown contextRef="c1">2600, Glostrup</c:AddressOfSubmittingEnterprisePostcodeAndTown><c:ReportingPeriodStartDate contextRef="c1">2014-07-01</c:ReportingPeriodStartDate><c:ReportingPeriodEndDate contextRef="c1">2015-06-30</c:ReportingPeriodEndDate><c:DateOfApprovalOfReport contextRef="c1">2015-12-04</c:DateOfApprovalOfReport><c:IdentificationNumberCvrOfReportingEntity contextRef="c1">32266355</c:IdentificationNumberCvrOfReportingEntity><c:NameOfReportingEntity contextRef="c1">Orphazyme ApS</c:NameOfReportingEntity><c:AddressOfReportingEntityStreetName contextRef="c1">c/o</c:AddressOfReportingEntityStreetName><c:AddressOfReportingEntityStreetBuildingIdentifier contextRef="c1">COBIS</c:AddressOfReportingEntityStreetBuildingIdentifier><c:AddressOfReportingEntityPostCodeIdentifier contextRef="c1">2200</c:AddressOfReportingEntityPostCodeIdentifier><c:AddressOfReportingEntityDistrictName contextRef="c1">København N</c:AddressOfReportingEntityDistrictName><c:HomepageOfReportingEntity contextRef="c1">www.orphazyme.com</c:HomepageOfReportingEntity><c:NameOfFinancialInstitution contextRef="c1">Danske Bank</c:NameOfFinancialInstitution><c:AddressOfFinancialStreetName contextRef="c1">Ãsterbrogade</c:AddressOfFinancialStreetName><c:AddressOfFinancialStreetBuildingIdentifier contextRef="c1">23</c:AddressOfFinancialStreetBuildingIdentifier><c:AddressOfFinancialPostCodeIdentifier contextRef="c1">2100</c:AddressOfFinancialPostCodeIdentifier><c:AddressOfFinancialDistrictName contextRef="c1">København Ã</c:AddressOfFinancialDistrictName><d:NameOfAuditFirm contextRef="c88">PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab</d:NameOfAuditFirm><d:IdentificationNumberCvrOfAuditFirm contextRef="c88">14119299</d:IdentificationNumberCvrOfAuditFirm><d:NameAndSurnameOfAuditor contextRef="c88">Kasper Vincelev</d:NameAndSurnameOfAuditor><d:DescriptionOfAuditor contextRef="c88">Statsautoriseret revisor</d:DescriptionOfAuditor><c:AddressOfAuditorStreetName contextRef="c88">Hovedvejen</c:AddressOfAuditorStreetName><c:AddressOfAuditorStreetBuildingIdentifier contextRef="c88">56</c:AddressOfAuditorStreetBuildingIdentifier><c:AddressOfAuditorPostCodeIdentifier contextRef="c88">2600</c:AddressOfAuditorPostCodeIdentifier><c:AddressOfAuditorDistrictName contextRef="c88">Glostrup</c:AddressOfAuditorDistrictName><c:AddressOfAuditorCountry contextRef="c1">Danmark</c:AddressOfAuditorCountry><c:TelephoneNumberOfAuditor contextRef="c88">43 96 06 56</c:TelephoneNumberOfAuditor><c:EmailOfAuditor contextRef="c1">pkf@pkf.dk</c:EmailOfAuditor><c:DateOfGeneralMeeting contextRef="c1">2015-12-04</c:DateOfGeneralMeeting><c:NameAndSurnameOfChairmanOfGeneralMeeting contextRef="c1">Georges Gemayel</c:NameAndSurnameOfChairmanOfGeneralMeeting><e:ClassOfReportingEntity contextRef="c1">Regnskabsklasse B</e:ClassOfReportingEntity><d:TypeOfAuditorAssistance contextRef="c1">RevisionspÃ¥tegning</d:TypeOfAuditorAssistance><f:AddresseeOfAuditorsReportOnAuditedFinancialStatements contextRef="c1">kapitalejerne</f:AddresseeOfAuditorsReportOnAuditedFinancialStatements><f:SignatureOfAuditorsPlace contextRef="c1">Glostrup</f:SignatureOfAuditorsPlace><f:SignatureOfAuditorsDate contextRef="c1">2015-12-04</f:SignatureOfAuditorsDate><g:PlaceOfSignatureOfStatement contextRef="c1">København N</g:PlaceOfSignatureOfStatement><g:DateOfApprovalOfAnnualReport contextRef="c1">2015-12-04</g:DateOfApprovalOfAnnualReport><e:GrossProfitLoss contextRef="c1" unitRef="u5" decimals="0">-25171578</e:GrossProfitLoss><e:GrossProfitLoss contextRef="c3" unitRef="u5" decimals="0">-26114055</e:GrossProfitLoss><e:EmployeeBenefitsExpense contextRef="c1" unitRef="u5" decimals="0">11427099</e:EmployeeBenefitsExpense><e:EmployeeBenefitsExpense contextRef="c3" unitRef="u5" decimals="0">11096973</e:EmployeeBenefitsExpense><e:DepreciationAmortisationExpenseAndImpairmentLossesOfPropertyPlantAndEquipmentAndIntangibleAssetsRecognisedInProfitOrLoss contextRef="c1" unitRef="u5" decimals="0">503783</e:DepreciationAmortisationExpenseAndImpairmentLossesOfPropertyPlantAndEquipmentAndIntangibleAssetsRecognisedInProfitOrLoss><e:DepreciationAmortisationExpenseAndImpairmentLossesOfPropertyPlantAndEquipmentAndIntangibleAssetsRecognisedInProfitOrLoss contextRef="c3" unitRef="u5" decimals="0">506463</e:DepreciationAmortisationExpenseAndImpairmentLossesOfPropertyPlantAndEquipmentAndIntangibleAssetsRecognisedInProfitOrLoss><e:ProfitLossFromOrdinaryOperatingActivities contextRef="c1" unitRef="u5" decimals="0">-37102460</e:ProfitLossFromOrdinaryOperatingActivities><e:ProfitLossFromOrdinaryOperatingActivities contextRef="c3" unitRef="u5" decimals="0">-37717491</e:ProfitLossFromOrdinaryOperatingActivities><e:OtherFinanceIncome contextRef="c1" unitRef="u5" decimals="0">34264</e:OtherFinanceIncome><e:OtherFinanceIncome contextRef="c3" unitRef="u5" decimals="0">96021</e:OtherFinanceIncome><e:OtherFinanceExpenses contextRef="c1" unitRef="u5" decimals="0">764928</e:OtherFinanceExpenses><e:OtherFinanceExpenses contextRef="c3" unitRef="u5" decimals="0">96727</e:OtherFinanceExpenses><e:ProfitLossFromOrdinaryActivitiesBeforeTax contextRef="c1" unitRef="u5" decimals="0">-37833124</e:ProfitLossFromOrdinaryActivitiesBeforeTax><e:ProfitLossFromOrdinaryActivitiesBeforeTax contextRef="c3" unitRef="u5" decimals="0">-37718197</e:ProfitLossFromOrdinaryActivitiesBeforeTax><e:TaxExpenseOnOrdinaryActivities contextRef="c1" unitRef="u5" decimals="0">-5875000</e:TaxExpenseOnOrdinaryActivities><e:TaxExpenseOnOrdinaryActivities contextRef="c3" unitRef="u5" decimals="0">-6250000</e:TaxExpenseOnOrdinaryActivities><e:ProfitLoss contextRef="c1" unitRef="u5" decimals="0">-31958124</e:ProfitLoss><e:ProfitLoss contextRef="c3" unitRef="u5" decimals="0">-31468197</e:ProfitLoss><e:ProfitLoss contextRef="c122" unitRef="u5" decimals="0">-31958124</e:ProfitLoss><e:ProfitLoss contextRef="c123" unitRef="u5" decimals="0">-31468197</e:ProfitLoss><e:FixturesFittingsToolsAndEquipment contextRef="c6" unitRef="u5" decimals="0">1748310</e:FixturesFittingsToolsAndEquipment><e:FixturesFittingsToolsAndEquipment contextRef="c4" unitRef="u5" decimals="0">1693723</e:FixturesFittingsToolsAndEquipment><e:PropertyPlantAndEquipment contextRef="c6" unitRef="u5" decimals="0">1748310</e:PropertyPlantAndEquipment><e:PropertyPlantAndEquipment contextRef="c4" unitRef="u5" decimals="0">1693723</e:PropertyPlantAndEquipment><e:NoncurrentAssets contextRef="c6" unitRef="u5" decimals="0">1748310</e:NoncurrentAssets><e:NoncurrentAssets contextRef="c4" unitRef="u5" decimals="0">1693723</e:NoncurrentAssets><e:ShorttermTaxReceivables contextRef="c6" unitRef="u5" decimals="0">12125000</e:ShorttermTaxReceivables><e:ShorttermTaxReceivables contextRef="c4" unitRef="u5" decimals="0">7500000</e:ShorttermTaxReceivables><e:OtherShorttermReceivables contextRef="c6" unitRef="u5" decimals="0">3220140</e:OtherShorttermReceivables><e:OtherShorttermReceivables contextRef="c4" unitRef="u5" decimals="0">448356</e:OtherShorttermReceivables><e:DeferredIncomeAssets contextRef="c6" unitRef="u5" decimals="0">290274</e:DeferredIncomeAssets><e:DeferredIncomeAssets contextRef="c4" unitRef="u5" decimals="0">189510</e:DeferredIncomeAssets><e:ShorttermReceivables contextRef="c6" unitRef="u5" decimals="0">15635414</e:ShorttermReceivables><e:ShorttermReceivables contextRef="c4" unitRef="u5" decimals="0">8137866</e:ShorttermReceivables><e:CashAndCashEquivalents contextRef="c6" unitRef="u5" decimals="0">78161074</e:CashAndCashEquivalents><e:CashAndCashEquivalents contextRef="c4" unitRef="u5" decimals="0">25732280</e:CashAndCashEquivalents><e:CurrentAssets contextRef="c6" unitRef="u5" decimals="0">93796488</e:CurrentAssets><e:CurrentAssets contextRef="c4" unitRef="u5" decimals="0">33870146</e:CurrentAssets><e:Assets contextRef="c6" unitRef="u5" decimals="0">95544798</e:Assets><e:Assets contextRef="c4" unitRef="u5" decimals="0">35563869</e:Assets><e:ContributedCapital contextRef="c6" unitRef="u5" decimals="0">3218031</e:ContributedCapital><e:ContributedCapital contextRef="c4" unitRef="u5" decimals="0">2175208</e:ContributedCapital><e:RetainedEarnings contextRef="c6" unitRef="u5" decimals="0">86523310</e:RetainedEarnings><e:RetainedEarnings contextRef="c4" unitRef="u5" decimals="0">29552031</e:RetainedEarnings><e:Equity contextRef="c6" unitRef="u5" decimals="0">89741341</e:Equity><e:Equity contextRef="c4" unitRef="u5" decimals="0">31727239</e:Equity><e:ShorttermDebtToBanks contextRef="c6" unitRef="u5" decimals="0">245151</e:ShorttermDebtToBanks><e:ShorttermDebtToBanks contextRef="c4" unitRef="u5" decimals="0">877</e:ShorttermDebtToBanks><e:ShorttermTradePayables contextRef="c6" unitRef="u5" decimals="0">3394496</e:ShorttermTradePayables><e:ShorttermTradePayables contextRef="c4" unitRef="u5" decimals="0">2082455</e:ShorttermTradePayables><e:OtherShorttermPayables contextRef="c6" unitRef="u5" decimals="0">2163810</e:OtherShorttermPayables><e:OtherShorttermPayables contextRef="c4" unitRef="u5" decimals="0">1753298</e:OtherShorttermPayables><e:ShorttermLiabilitiesOtherThanProvisions contextRef="c6" unitRef="u5" decimals="0">5803457</e:ShorttermLiabilitiesOtherThanProvisions><e:ShorttermLiabilitiesOtherThanProvisions contextRef="c4" unitRef="u5" decimals="0">3836630</e:ShorttermLiabilitiesOtherThanProvisions><e:LiabilitiesOtherThanProvisions contextRef="c6" unitRef="u5" decimals="0">5803457</e:LiabilitiesOtherThanProvisions><e:LiabilitiesOtherThanProvisions contextRef="c4" unitRef="u5" decimals="0">3836630</e:LiabilitiesOtherThanProvisions><e:LiabilitiesAndEquity contextRef="c6" unitRef="u5" decimals="0">95544798</e:LiabilitiesAndEquity><e:LiabilitiesAndEquity contextRef="c4" unitRef="u5" decimals="0">35563869</e:LiabilitiesAndEquity><e:WagesAndSalaries contextRef="c1" unitRef="u5" decimals="0">10566745</e:WagesAndSalaries><e:WagesAndSalaries contextRef="c3" unitRef="u5" decimals="0">10100420</e:WagesAndSalaries><e:PostemploymentBenefitExpense contextRef="c1" unitRef="u5" decimals="0">796885</e:PostemploymentBenefitExpense><e:PostemploymentBenefitExpense contextRef="c3" unitRef="u5" decimals="0">908016</e:PostemploymentBenefitExpense><e:SocialSecurityContributions contextRef="c1" unitRef="u5" decimals="0">33030</e:SocialSecurityContributions><e:SocialSecurityContributions contextRef="c3" unitRef="u5" decimals="0">30510</e:SocialSecurityContributions><e:OtherEmployeeExpense contextRef="c1" unitRef="u5" decimals="0">30439</e:OtherEmployeeExpense><e:OtherEmployeeExpense contextRef="c3" unitRef="u5" decimals="0">58027</e:OtherEmployeeExpense><e:EmployeeBenefitsExpense contextRef="c1" unitRef="u5" decimals="0">11427099</e:EmployeeBenefitsExpense><e:EmployeeBenefitsExpense contextRef="c3" unitRef="u5" decimals="0">11096973</e:EmployeeBenefitsExpense><e:PropertyPlantAndEquipmentGross contextRef="c160" unitRef="u5" decimals="0">2305638</e:PropertyPlantAndEquipmentGross><e:AdditionsToPropertyPlantAndEquipment contextRef="c161" unitRef="u5" decimals="0">558369</e:AdditionsToPropertyPlantAndEquipment><e:PropertyPlantAndEquipmentGross contextRef="c162" unitRef="u5" decimals="0">2864007</e:PropertyPlantAndEquipmentGross><e:AccumulatedImpairmentLossesAndDepreciationOfPropertyPlantAndEquipment contextRef="c160" unitRef="u5" decimals="0">611915</e:AccumulatedImpairmentLossesAndDepreciationOfPropertyPlantAndEquipment><e:DepreciationOfPropertyPlantAndEquipment contextRef="c161" unitRef="u5" decimals="0">503782</e:DepreciationOfPropertyPlantAndEquipment><e:AccumulatedImpairmentLossesAndDepreciationOfPropertyPlantAndEquipment contextRef="c162" unitRef="u5" decimals="0">1115697</e:AccumulatedImpairmentLossesAndDepreciationOfPropertyPlantAndEquipment><e:PropertyPlantAndEquipment contextRef="c162" unitRef="u5" decimals="0">1748310</e:PropertyPlantAndEquipment><e:Equity contextRef="c181" unitRef="u5" decimals="0">3218031</e:Equity><e:Equity contextRef="c720" unitRef="u5" decimals="0">2175208</e:Equity><e:Equity contextRef="c183" unitRef="u5" decimals="0">3218031</e:Equity><e:Equity contextRef="c722" unitRef="u5" decimals="0">2175208</e:Equity><e:TransferredFromSharePremium contextRef="c185" unitRef="u5" decimals="0">88929403</e:TransferredFromSharePremium><e:TransferredFromSharePremium contextRef="c727" unitRef="u5" decimals="0">0</e:TransferredFromSharePremium><e:ValueAdjustmentsOfEquity contextRef="c185" unitRef="u5" decimals="0">-88929403</e:ValueAdjustmentsOfEquity><e:ValueAdjustmentsOfEquity contextRef="c727" unitRef="u5" decimals="0">0</e:ValueAdjustmentsOfEquity><e:Equity contextRef="c199" unitRef="u5" decimals="0">29552031</e:Equity><e:Equity contextRef="c741" unitRef="u5" decimals="0">61020228</e:Equity><e:ProfitLoss contextRef="c200" unitRef="u5" decimals="0">-31958124</e:ProfitLoss><e:ProfitLoss contextRef="c742" unitRef="u5" decimals="0">-31468197</e:ProfitLoss><e:ValueAdjustmentsOfEquity contextRef="c200" unitRef="u5" decimals="0">88929403</e:ValueAdjustmentsOfEquity><e:ValueAdjustmentsOfEquity contextRef="c742" unitRef="u5" decimals="0">0</e:ValueAdjustmentsOfEquity><e:Equity contextRef="c201" unitRef="u5" decimals="0">86523310</e:Equity><e:Equity contextRef="c743" unitRef="u5" decimals="0">29552031</e:Equity><d:NameAndSurnameOfMemberOfExecutiveBoard contextRef="c71">Anders Mørkeberg Hinsby</d:NameAndSurnameOfMemberOfExecutiveBoard><d:NameAndSurnameOfMemberOfSupervisoryBoard contextRef="c32">Georges Gemayel</d:NameAndSurnameOfMemberOfSupervisoryBoard><d:NameAndSurnameOfMemberOfSupervisoryBoard contextRef="c48">Sten Verland</d:NameAndSurnameOfMemberOfSupervisoryBoard><d:NameAndSurnameOfMemberOfSupervisoryBoard contextRef="c49">Patrick Johan Hendrik Krol</d:NameAndSurnameOfMemberOfSupervisoryBoard><d:TitleOfMemberOfSupervisoryBoard contextRef="c32">formand</d:TitleOfMemberOfSupervisoryBoard><d:NameAndSurnameOfMemberOfSupervisoryBoard contextRef="c50">Kim Lennart Dueholm</d:NameAndSurnameOfMemberOfSupervisoryBoard><d:NameAndSurnameOfMemberOfSupervisoryBoard contextRef="c51">Martin Bonde</d:NameAndSurnameOfMemberOfSupervisoryBoard><d:NameAndSurnameOfMemberOfSupervisoryBoard contextRef="c52">Bo Jesper Hansen</d:NameAndSurnameOfMemberOfSupervisoryBoard><d:NameAndSurnameOfMemberOfSupervisoryBoard contextRef="c53">Martin Rahbek Kornum</d:NameAndSurnameOfMemberOfSupervisoryBoard><d:NameAndSurnameOfMemberOfSupervisoryBoard contextRef="c54">Rémi Pascal Louis Droller</d:NameAndSurnameOfMemberOfSupervisoryBoard><e:GrossResult contextRef="c261" unitRef="u5" decimals="-3">-29166000</e:GrossResult><e:GrossResult contextRef="c264" unitRef="u5" decimals="-3">-13671000</e:GrossResult><e:GrossResult contextRef="c267" unitRef="u5" decimals="-3">7928000</e:GrossResult><e:ProfitLossFromOrdinaryOperatingActivities contextRef="c261" unitRef="u5" decimals="-3">-36959000</e:ProfitLossFromOrdinaryOperatingActivities><e:ProfitLossFromOrdinaryOperatingActivities contextRef="c264" unitRef="u5" decimals="-3">-18560000</e:ProfitLossFromOrdinaryOperatingActivities><e:ProfitLossFromOrdinaryOperatingActivities contextRef="c267" unitRef="u5" decimals="-3">-10017000</e:ProfitLossFromOrdinaryOperatingActivities><e:ResultsFromNetFinancials contextRef="c1" unitRef="u5" decimals="-3">-731000</e:ResultsFromNetFinancials><e:ResultsFromNetFinancials contextRef="c3" unitRef="u5" decimals="-3">-1000</e:ResultsFromNetFinancials><e:ResultsFromNetFinancials contextRef="c261" unitRef="u5" decimals="-3">-54000</e:ResultsFromNetFinancials><e:ResultsFromNetFinancials contextRef="c264" unitRef="u5" decimals="-3">523000</e:ResultsFromNetFinancials><e:ResultsFromNetFinancials contextRef="c267" unitRef="u5" decimals="-3">4000</e:ResultsFromNetFinancials><e:ProfitLoss contextRef="c261" unitRef="u5" decimals="-3">-35763000</e:ProfitLoss><e:ProfitLoss contextRef="c264" unitRef="u5" decimals="-3">-16787000</e:ProfitLoss><e:ProfitLoss contextRef="c267" unitRef="u5" decimals="-3">-10013000</e:ProfitLoss><e:Assets contextRef="c263" unitRef="u5" decimals="-3">65921000</e:Assets><e:Assets contextRef="c266" unitRef="u5" decimals="-3">60757000</e:Assets><e:Assets contextRef="c269" unitRef="u5" decimals="-3">12841000</e:Assets><e:Equity contextRef="c263" unitRef="u5" decimals="-3">63195000</e:Equity><e:Equity contextRef="c266" unitRef="u5" decimals="-3">57239000</e:Equity><e:Equity contextRef="c269" unitRef="u5" decimals="-3">11445000</e:Equity><g:IdentificationOfApprovedAnnualReport contextRef="c1">Bestyrelse og direktion har dags dato aflagt Ã¥rsrapporten for 2014/15 for Orphazyme ApS.
The board of directors and the managing director have today presented the annual report of Orphazyme ApS for the financial year 1 July 2014 to 30 June 2015.
</g:IdentificationOfApprovedAnnualReport><g:ConfirmationThatAnnualReportIsPresentedInAccordanceWithRequirementsProvidedForByLegislationAnyStandardsAndRequirementsProvidedByArticlesOfAssociationOrByAgreement contextRef="c1">Ã
rsrapporten er aflagt i overensstemmelse med årsregnskabsloven.
The annual report has been presented in accordance with the Danish Financial Statements Act.
</g:ConfirmationThatAnnualReportIsPresentedInAccordanceWithRequirementsProvidedForByLegislationAnyStandardsAndRequirementsProvidedByArticlesOfAssociationOrByAgreement><g:ConfirmationThatFinancialStatementGivesTrueAndFairViewOfAssetsLiabilitiesEquityFinancialPositionAndResults contextRef="c1">Vi anser den valgte regnskabspraksis for hensigtsmæssig, og efter vores opfattelse giver årsregnskabet et retvisende billede af selskabets aktiver, passiver og finansielle stilling pr. 30. juni 2015 samt af resultatet af selskabets aktiviteter for regnskabsåret 1. juli 2014 - 30. juni 2015.
We consider the accounting policies used appropriate, and in our opinion the annual accounts provide a true and fair view of the company's assets and liabilities and its financial position as on 30 June 2015 and of the company's results of its activities in the financial year 1 July 2014 to 30 June 2015.
</g:ConfirmationThatFinancialStatementGivesTrueAndFairViewOfAssetsLiabilitiesEquityFinancialPositionAndResults><g:ManagementsStatementAboutManagementsReview contextRef="c1">Ledelsesberetningen indeholder efter vores opfattelse en retvisende redegørelse for de forhold, som beretningen omhandler.
We are of the opinion that the management's review includes a fair description of the issues dealt with.
</g:ManagementsStatementAboutManagementsReview><g:RecommendationForApprovalOfAnnualReportByGeneralMeeting contextRef="c1">Ã
rsrapporten indstilles til generalforsamlingens godkendelse
The annual report is recommended for approval by the general meeting
</g:RecommendationForApprovalOfAnnualReportByGeneralMeeting><f:IdentificationOfAuditedFinancialStatements contextRef="c1">Vi har revideret Ã¥rsregnskabet for Orphazyme ApS for regnskabsÃ¥ret 1. juli 2014 - 30. juni 2015, der omfatter anvendt regnskabspraksis, resultatopgørelse, balance og noter. Ã
rsregnskabet udarbejdes efter årsregnskabsloven.
We have audited the annual accounts of Orphazyme ApS for the financial year 1 July 2014 to 30 June 2015, which comprise accounting policies used, profit and loss account, balance sheet and notes. The annual accounts are prepared in accordance with the Danish Financial Statements Act.
</f:IdentificationOfAuditedFinancialStatements><f:StatementOfExecutiveAndSupervisoryBoardsResponsibilityForFinancialStatements contextRef="c1">Ledelsen har ansvaret for udarbejdelsen af et årsregnskab, der giver et retvisende billede i overensstemmelse med årsregnskabsloven. Ledelsen har endvidere ansvaret for den interne kontrol, som ledelsen anser nødvendig for at udarbejde et årsregnskab uden væsentlig fejlinformation, uanset om denne skyldes besvigelser eller fejl.
The management is responsible for the preparation of annual accounts that give a true and fair view in accordance with the Danish Financial Statements Act. Furthermore, the management is responsible for such internal control as it determines necessary in order to prepare annual accounts that are free from material misstatement, whether due to fraud or error.
</f:StatementOfExecutiveAndSupervisoryBoardsResponsibilityForFinancialStatements><f:StatementOfAuditorsResponsibilityForAuditAndAuditPerformed contextRef="c1">Vores ansvar er at udtrykke en konklusion om årsregnskabet på grundlag af vores revision. Vi har udført revisionen i overensstemmelse med internationale standarder om revision og yderligere krav ifølge dansk revisorlovgivning. Dette kræver, at vi overholder etiske krav samt planlægger og udfører revisionen for at opnå høj grad af sikkerhed for, om årsregnskabet er uden væsentlig fejlinformation.
Our responsibility is to express an opinion on the annual accounts based on our audit. We conducted our audit in accordance with international standards on auditing and additional requirements under Danish audit regulation. This requires that we comply with ethical requirements and plan and perform the audit to obtain reasonable assurance about whether the annual accounts are free from material misstatements.
En revision omfatter udførelse af revisionshandlinger for at opnå revisionsbevis for beløb og oplysninger i årsregnskabet. De valgte revisionshandlinger afhænger af revisors vurdering, herunder vurdering af risici for væsentlig fejlinformation i årsregnskabet, uanset om denne skyldes besvigelser eller fejl. Ved risikovurderingen overvejer revisor intern kontrol, der er relevant for selskabets udarbejdelse af et årsregnskab, der giver et retvisende billede. Formålet hermed er at udforme revisionshandlinger, der er passende efter omstændighederne, men ikke at udtrykke en konklusion om effektiviteten af selskabets interne kontrol. En revision omfatter endvidere vurdering af, om ledelsens valg af regnskabspraksis er passende, om ledelsens regnskabsmæssige skøn er rimelige samt den samlede præsentation af årsregnskabet.
An audit involves performing procedures to obtain audit evidence about the amounts and disclosures in the annual accounts. The procedures selected depend on the auditor's judgement, including the assessment of the risks of material misstatements in the annual accounts, whether due to fraud or error. In making those risk assessments, the auditor considers internal control relevant to the company's preparation of annual accounts that give a true and fair view in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the company's internal control. An audit also includes evaluating the appropriateness of accounting policies used and the reasonableness of accounting estimates made by the management, as well as the overall presentation of the annual accounts.
Det er vores opfattelse, at det opnåede revisionsbevis er tilstrækkeligt og egnet som grundlag for vores konklusion.
We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Revisionen har ikke givet anledning til forbehold.
The audit has not resulted in any qualification.
</f:StatementOfAuditorsResponsibilityForAuditAndAuditPerformed><f:OpinionOnAuditedFinancialStatements contextRef="c1">Det er vores opfattelse, at årsregnskabet giver et retvisende billede af selskabets aktiver, passiver og finansielle stilling pr. 30. juni 2015 samt af resultatet af selskabets aktiviteter for regnskabsåret 1. juli 2014 - 30. juni 2015 i overensstemmelse med årsregnskabsloven.
In our opinion, the annual accounts give a true and fair view of the company's assets, liabilities and financial position at 30 June 2015 and of the results of the company's operations for the financial year 1 July 2014 to 30 June 2015 in accordance with the Danish Financial Statements Act.
</f:OpinionOnAuditedFinancialStatements><f:StatementOnManagementsReviewAuditorsReportOnAuditedFinancialStatements contextRef="c1">Vi har i henhold til årsregnskabsloven gennemlæst ledelsesberetningen. Vi har ikke foretaget yderligere handlinger i tillæg til den udførte revision af årsregnskabet. Det er på denne baggrund vores opfattelse, at oplysningerne i ledelsesberetningen er i overensstemmelse med årsregnskabet.
Pursuant to the Danish Financial Statements Act, we have read the management's review. We have not performed any further procedures in addition to the audit of the annual accounts. On this basis, it is our opinion that the information provided in the management's review is consistent with the annual accounts.
</f:StatementOnManagementsReviewAuditorsReportOnAuditedFinancialStatements><h:ManagementsReview contextRef="c1">Virksomhedens væsentligste aktiviteter
The principal activities of the enterprise
Orphazymes mission er at udvikle en ny klasse af lægemidler til behandling af genetiske og degenerative sygdomme. Orphazymes programmer er i præklinisk/klinisk udvikling til behandling af lysosomale ophobningssygdomme samt andre neurodegenerative sygdomme såsom ALS.
Orphazyme is dedicated to the development of a novel class of therapeutics for the treatment of genetic and degenerative diseases. Orphazymeâs programs are in preclinical/clinical development as potential treatments for lysosomal storage diseases and other neurodegenerative diseases such as ALS. Orphazymes første projekt er at udvikle lægemidler til behandling af lysosomale ophobningssygdomme: En familie der bestÃ¥r af mere end 50 genetiske sygdomme, der samlet har en incidens pÃ¥ 1 ud af 10.000 fødsler. Lægemiddeludviklingen er baseret pÃ¥ en proprietær viden omkring heat-shock proteiners cellebeskyttende egenskaber. Orphazymeâs lead project is to develop new medicine for the treatment of lysosomal storage diseases, a family of more than 50 genetic disorders that occur in 1:10.000 births. The company applies proprietary know-how and technology based on the cytoprotective properties of heat-shock proteins. Arimoclomol kan effektivt behandle celler udtaget fra patienter, der lider af lysosomale ophobningssygdomme, og for hvem der i dag ikke findes en effektiv behandling. Arimoclomol har ogsÃ¥ vist en gavnlig effekt i dyremodeller, hvilket yderligere understreger det terapeutiske potentiale. Et klinisk program i Niemann-Pickâs sygdom (type C), en debiliterende og dødelig lysosomal ophobningssygdom, forventes at starte rekruttering i 2015. Ydermere er Arimoclomol i klinisk udvikling som behandling til en genetisk defineret gruppe af patienter, der lider af motorneuron sygdommen ALS. Arimoclomol effectively treats cells from patients suffering from different lysosomal storage diseases, for which there is no current treatment available. Arimoclomol has also exhibited therapeutic effect in animal disease models further substantiating its therapeutic potential. A clinical program in Niemann Pick disease type C, a debilitating and ultimately fatal lysosomal storage disease, is expected to start enrolling patients in 2015. Moreover, Arimoclomol is currently in clinical development in a genetically defined subpopulation of patients suffering from the motorneuron disease ALS.
Udvikling i aktiviteter og økonomiske forhold
Development in activities and financial affairs
Ã
rets bruttotab udgør -25,2 mio. kr. mod -26,1 mio. kr. sidste år. Det ordinære resultat efter skat udgør -32,0 mio. kr. mod -31,5 mio. kr. sidste år. Ledelsen anser årets resultat for tilfredsstillende.
The gross loss for the year is DKK -25,2m against DKK -26,1m last year. The results from ordinary activities after tax are DKK -32,0m against DKK -31,5m last year. The management considers the results satisfactory.
Begivenheder efter regnskabsårets udløb
Events subsequent to the end of the financial year
Efter regnskabsårets afslutning er der ikke indtruffet begivenheder, som vil kunne forrykke selskabets finansielle stilling væsentligt.
No events have occurred subsequent to the balance sheet date, which would have material impact on the financial position of the company.
</h:ManagementsReview><e:InformationOnReportingClassOfEntity contextRef="c1">Ã
rsrapporten for Orphazyme ApS er aflagt i overensstemmelse med årsregnskabslovens bestemmelser for en klasse B-virksomhed.
The annual report for Orphazyme ApS is presented in accordance with those regulations of the Danish Financial Statements Act concerning companies identified as class B enterprises.
Ã
rsrapporten er aflagt efter samme regnskabspraksis som sidste år og aflægges i danske kroner.
The accounting policies used are unchanged compared to last year, and the annual accounts are presented in Danish kroner (DKK).
</e:InformationOnReportingClassOfEntity><e:DescriptionOfGeneralMattersRelatedToRecognitionMeasurementAndChangesInAccountingPolicies contextRef="c1">Generelt om indregning og måling
Recognition and measurement in general
I resultatopgørelsen indregnes indtægter i takt med, at de indtjenes. Herunder indregnes værdireguleringer af finansielle aktiver og forpligtelser. I resultatopgørelsen indregnes ligeledes alle omkostninger, herunder afskrivninger, nedskrivninger og hensatte forpligtelser samt tilbageførsler som følge af ændrede regnskabsmæssige skøn af beløb, der tidligere har været indregnet i resultatopgørelsen.
Income is recognised in the profit and loss account concurrently with its realisation, including the recognition of value adjustments of financial assets and liabilities. Likewise, all costs, these including depreciation, amortisation, writedown, provisions, and reversals which are due to changes in estimated amounts previously recognised in the profit and loss account are recognised in the profit and loss account.
Aktiver indregnes i balancen, når det er sandsynligt, at fremtidige økonomiske fordele vil tilflyde selskabet, og aktivets værdi kan måles pålideligt.
Assets are recognised in the balance sheet when the company is liable to achieve future, financial benefits and the value of the asset can be measured reliably.
Forpligtelser indregnes i balancen, når det er sandsynligt, at fremtidige økonomiske fordele vil fragå selskabet, og forpligtelsens værdi kan måles pålideligt.
Liabilities are recognised in the balance sheet when the company is liable to loose future, financial benefits and the value of the liability can be measured reliably.
Ved første indregning måles aktiver og forpligtelser til kostpris. Efterfølgende måles aktiver og forpligtelser som beskrevet nedenfor for hver enkelt regnskabspost.
At the first recognition, assets and liabilities are measured at cost. Later, assets and liabilities are measured as described below for each individual accounting item.
Visse finansielle aktiver og forpligtelser måles til amortiseret kostpris, hvorved der indregnes en konstant effektiv rente over løbetiden. Amortiseret kostpris opgøres som oprindelig kostpris med fradrag af eventuelle afdrag samt tillæg/fradrag af den akkumulerede amortisering af forskellen mellem kostpris og nominelt beløb. Herved fordeles kurstab og kursgevinst over aktivets eller forpligtelsens løbetid.
Certain fixed asset investments and liabilities are measured at amortised cost, by which method a fixed, effective interest is recognised during the useful life of the asset or the liability. Amortised cost is recognised as the original cost with deduction of any payments and additions/deductions of the accrued amortisation of the difference between cost and nominal amount. In this way capital losses and capital profits are spread over the useful life.
Ved indregning og måling tages hensyn til forudsigelige tab og risici, der fremkommer inden årsrapporten aflægges, og som vedrører forhold, der eksisterede på balancedagen.
At recognition and measurement, such predictable losses and risks are taken into consideration, which may appear before the annual report is presented, and which concerns matters existing on the balance sheet date.
</e:DescriptionOfGeneralMattersRelatedToRecognitionMeasurementAndChangesInAccountingPolicies><e:DescriptionOfMethodsOfForeignCurrencies contextRef="c1">Omregning af fremmed valuta
Translation of foreign currency
Transaktioner i fremmed valuta omregnes til transaktionsdagens kurs. Valutakursdifferencer, der opstår mellem transaktionsdagens kurs og kursen på betalingsdagen, indregnes i resultatopgørelsen som en finansiel post.
Transactions in foreign currency are translated by using the exchange rate prevailing at the date of the transaction. Differences in the rate of exchange arising between the rate at the date of transaction and the rate at the date of payment are recognised in the profit and loss account as an item under net financials.
Tilgodehavender, gæld og andre monetære poster i fremmed valuta, som ikke er afregnet på balancedagen, omregnes til balancedagens valutakurs. Forskellen mellem balancedagens kurs og kursen på tidspunktet for tilgodehavendets eller gældens opståen indregnes i resultatopgørelsen under finansielle indtægter og omkostninger.
Debtors, creditors, and other monetary items in foreign currency, which are not settled at the date of the balance sheet, are translated by using the closing rate. The difference between the closing rate and the rate at the time of establishment of the receivable or the payable is recognised in the profit and loss account under financial income and financial costs.
</e:DescriptionOfMethodsOfForeignCurrencies><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfRevenue contextRef="c1">Bruttotab
Gross loss
Bruttotab indeholder eksterne omkostninger.
The gross loss consists of external costs.
</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfRevenue><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfExternalExpenses contextRef="c1">Andre eksterne omkostninger omfatter omkostninger til salg, lokaler, administration samt omkostninger afholdt til forskning, udvikling og patenter.
Other external costs comprise costs for sales, premises, administration, as well as research, development and patent costs.
</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfExternalExpenses><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfEmployeeBenefitExpense contextRef="c1">Personaleomkostninger
Staff costs
Personaleomkostninger omfatter løn og gager, inklusive feriepenge og pensioner samt andre omkostninger til social sikring mv. til selskabets medarbejdere. I personaleomkostninger er fratrukket modtagne godtgørelser fra offentlige myndigheder.
Staff costs include salaries and wages including holiday allowances, pensions and other costs for social security etc. for staff members. Staff costs are less public reimbursements.
</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfEmployeeBenefitExpense><e:DescriptionOfMethodsOfImpairmentLossesAndDepreciation contextRef="c1">Af- og nedskrivninger
Depreciation, amortisation and writedown
Af- og nedskrivninger indeholder årets af- og nedskrivninger samt fortjeneste og tab ved salg af immaterielle og materielle anlægsaktiver.
Depreciation, amortisation and writedown comprise depreciation, amortisation and writedown for the year and gains and losses on disposal of intangible and tangible fixed assets.
</e:DescriptionOfMethodsOfImpairmentLossesAndDepreciation><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfFinanceIncomeAndExpenses contextRef="c1">Finansielle poster
Net financials
Finansielle poster omfatter renteindtægter og -omkostninger samt realiserede og urealiserede kursavancer og -tab vedrørende finansielle aktiver og forpligtelser. Finansielle indtægter og omkostninger indregnes i resultatopgørelsen med de beløb, der vedrører regnskabsåret.
Net financials include interest income, interest expenses, and realised and unrealised capital gains and losses on financial assets and liabilities. Net financials are recognised in the profit and loss account with the amounts concerning the financial year.
</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfFinanceIncomeAndExpenses><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfTaxExpenses contextRef="c1">Skat af årets resultat
Tax of the results for the year
Ã
rets skat, der består af årets aktuelle selskabsskat og ændring i udskudt skat, indregnes i resultatopgørelsen med den del, der kan henføres til årets resultat, og direkte i egenkapitalen med den del, der kan henføres til posteringer direkte på egenkapitalen.
The tax for the year comprises the current tax for the year and the changes in deferred tax, and it is recognised in the profit and loss account with the share referring to the results for the year and directly in the equity with the share referring to entries directly on the equity.
</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfTaxExpenses><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfPropertyPlantAndEquipment contextRef="c1">Materielle anlægsaktiver
Tangible fixed assets
Materielle anlægsaktiver måles til kostpris med fradrag af akkumulerede afskrivninger og nedskrivninger.
Tangible fixed assets are measured at cost with deduction of accrued depreciation and writedown.
Afskrivningsgrundlaget er kostpris med fradrag af forventet restværdi efter afsluttet brugstid.
The basis of depreciation is cost with deduction of expected residual value after the end of the useful life of the asset.
Kostprisen omfatter anskaffelsesprisen samt omkostninger direkte tilknyttet anskaffelsen indtil det tidspunkt, hvor aktivet er klar til at blive taget i brug.
The cost comprises the acquisition cost and costs directly attached to the acquisition until the time when the asset is ready for use.
Der foretages lineære afskrivninger baseret på følgende vurdering af aktivernes forventede brugstider:
Depreciation takes place on a straight line basis and based on an evaluation of the expected useful life:
Andre anlæg, driftsmateriel og inventar
Other plants, operating assets, fixtures and furniture
3-5
Ã¥r
/
years
Aktiver med en kostpris på under 13 t.kr. pr. enhed indregnes i anskaffelsesåret som omkostninger i resultatopgørelsen.
Assets with a cost of less than TDKK 13 per unit are recognised as costs in the profit and loss account in the year of acquisition.
Fortjeneste eller tab ved afhændelse af materielle anlægsaktiver opgøres som forskellen mellem salgspris med fradrag af salgsomkostninger og den regnskabsmæssige værdi på salgstidspunktet. Fortjeneste eller tab indregnes i resultatopgørelsen under af- og nedskrivninger.
Profit or loss deriving from the sales of tangible fixed assets is measured as the difference between the sales price reduced by the selling costs and the book value at the time of the sale. Profit or loss is recognised in the profit and loss account under depreciation.
</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfPropertyPlantAndEquipment><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfReceivables contextRef="c1">Tilgodehavender
Debtors
Tilgodehavender måles til amortiseret kostpris, hvilket sædvanligvis svarer til nominel værdi. Der nedskrives til nettorealisationsværdien med henblik på at imødegå forventede tab.
Debtors are measured at amortised cost which usually corresponds to face value. In order to meet expected losses, writedown takes place at the net realisable value.
</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfReceivables><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfDeferredIncomeAssets contextRef="c1">Periodeafgrænsningsposter
Accrued income and deferred expenses
Periodeafgrænsningsposter, som er indregnet under aktiver, omfatter afholdte omkostninger vedrørende efterfølgende regnskabsår.
Accrued income and deferred expenses recognised under assets comprise incurred costs concerning the next financial year.
</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfDeferredIncomeAssets><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfCashAndCashEquivalents contextRef="c1">Likvide beholdninger
Available funds
Likvide beholdninger omfatter indeståender i pengeinstitutter og kontantbeholdninger.
Available funds comprise cash at bank and in hand.
</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfCashAndCashEquivalents><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfTaxPayablesAndDeferredTax contextRef="c1">Selskabsskat og udskudt skat
Corporate tax and deferred tax
Aktuelle skattetilgodehavender og -forpligtelser indregnes i balancen med det beløb, der kan beregnes på grundlag af årets forventede skattepligtige indkomst reguleret for skat af tidligere års skattepligtige indkomster samt for betalte acontoskatter. Skattetilgodehavender og -forpligtelser præsenteres modregnet i det omfang, der er legal modregningsadgang, og posterne forventes afregnet netto eller samtidig.
Current tax receivable and tax liabilities are recognised in the balance sheet at the amount calculated on the basis of the expected taxable income for the year adjusted for tax on previous years' taxable income and prepaid taxes. Tax receivable and tax liabilities are set off to the extent that legal right of set-off exists and if the items are expected to be settled net or simultaneously.
Udskudt skat er skatten af alle midlertidige forskelle mellem regnskabsmæssig og skattemæssig værdi af aktiver og forpligtelser opgjort på grundlag af den planlagte anvendelse af aktivet henholdsvis afvikling af forpligtelsen.
Deferred tax is measured on the basis of all temporary differences in assets and liabilities with a balance sheet focus.
Udskudt skat måles på grundlag af de skatteregler og skattesatser, der med balancedagens lovgivning vil være gældende, når den udskudte skat forventes udløst som aktuel skat. Selskabsskatteprocenten vil i perioden fra 2015 til 2016 blive trinvist nedsat fra 23,5 % til 22 %, hvilket vil påvirke størrelsen af udskudte skatteforpligtelser og skatteaktiver. Medmindre en indregning med en anden skatteprocent end 22 vil medføre en væsentlig afvigelse i den forventede udskudte skatteforpligtelse eller skatteaktivet, indregnes udskudte skatteforpligtelser og skatteaktiver med 22 %.
Deferred tax is measured based on the tax rules and tax rates applying under the legislation on the balance sheet date and prevailing when the deferred tax is expected to be released as current tax. In the period 2015 to 2016, the corporate tax rate will be reduced gradually from 23,5 % to 22 %, which will affect the deferred tax liabilities and deferred tax assets. Unless a recognition with a different tax rate than 22 % will result in a significant material deviation in the estimated deferred tax liability or tax asset, deferred tax liabilities and assets are recognised by 22 %.
</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfTaxPayablesAndDeferredTax><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfLiabilitiesOtherThanProvisions contextRef="c1">Gældsforpligtelser
Liabilities
Andre gældsforpligtelser måles til amortiseret kostpris, hvilket sædvanligvis svarer til nominel værdi.
Other liabilities are measured at amortised cost which usually corresponds to the nominal value.
</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfLiabilitiesOtherThanProvisions><e:DisclosureOfContingentLiabilities contextRef="c1">8. Eventualposter
Contingencies
Eventualaktiver
Contingent assets
Selskabet har et ikke-indregnet udskudt skatteaktiv på 17.768 t.kr., da der er usikkerhed om, hvornår det kan udnyttes i fremtidig indtjening.
A deferred tax asset of TDKK 17.768 has not been recognized due to uncertainty regarding future usage.
Eventualforpligtelser
Contingent liabilities
Selskabet har indgået aftale om leje af lokaler. Den årlige leje udgør 557 t.kr. Aftalen kan opsiges med 6 måneders varsel.
The company has entered a leasehold contract with annual payment of TDKK 557. The contract can be terminated with 6 months ntice.
</e:DisclosureOfContingentLiabilities><!--Aktuelle periode enkelt selskab--><context id="c1"><entity><identifier scheme="http://www.dcca.dk/cvr">32266355</identifier></entity><period><startDate>2014-07-01</startDate><endDate>2015-06-30</endDate></period></context><!--Forrige periode enkelt selskab--><context id="c3"><entity><identifier scheme="http://www.dcca.dk/cvr">32266355</identifier></entity><period><startDate>2013-07-01</startDate><endDate>2014-06-30</endDate></period></context><!--Slutdato forrige periode enkelt selskab--><context id="c4"><entity><identifier scheme="http://www.dcca.dk/cvr">32266355</identifier></entity><period><instant>2014-06-30</instant></period></context><!--Slutdato aktuelle periode enkelt selskab--><context id="c6"><entity><identifier scheme="http://www.dcca.dk/cvr">32266355</identifier></entity><period><instant>2015-06-30</instant></period></context><!--BOARD1--><context id="c32"><entity><identifier scheme="http://www.dcca.dk/cvr">32266355</identifier></entity><period><startDate>2014-07-01</startDate><endDate>2015-06-30</endDate></period><scenario><xbrldi:typedMember dimension="d:IdentificationOfMemberOfSupervisoryBoardDimension"><d:memberOfBoardIdentifier>1</d:memberOfBoardIdentifier></xbrldi:typedMember></scenario></context><!--BOARD2--><context id="c48"><entity><identifier scheme="http://www.dcca.dk/cvr">32266355</identifier></entity><period><startDate>2014-07-01</startDate><endDate>2015-06-30</endDate></period><scenario><xbrldi:typedMember dimension="d:IdentificationOfMemberOfSupervisoryBoardDimension"><d:memberOfBoardIdentifier>2</d:memberOfBoardIdentifier></xbrldi:typedMember></scenario></context><!--BOARD3--><context id="c49"><entity><identifier scheme="http://www.dcca.dk/cvr">32266355</identifier></entity><period><startDate>2014-07-01</startDate><endDate>2015-06-30</endDate></period><scenario><xbrldi:typedMember dimension="d:IdentificationOfMemberOfSupervisoryBoardDimension"><d:memberOfBoardIdentifier>3</d:memberOfBoardIdentifier></xbrldi:typedMember></scenario></context><!--BOARD4--><context id="c50"><entity><identifier scheme="http://www.dcca.dk/cvr">32266355</identifier></entity><period><startDate>2014-07-01</startDate><endDate>2015-06-30</endDate></period><scenario><xbrldi:typedMember dimension="d:IdentificationOfMemberOfSupervisoryBoardDimension"><d:memberOfBoardIdentifier>4</d:memberOfBoardIdentifier></xbrldi:typedMember></scenario></context><!--BOARD5--><context id="c51"><entity><identifier scheme="http://www.dcca.dk/cvr">32266355</identifier></entity><period><startDate>2014-07-01</startDate><endDate>2015-06-30</endDate></period><scenario><xbrldi:typedMember dimension="d:IdentificationOfMemberOfSupervisoryBoardDimension"><d:memberOfBoardIdentifier>5</d:memberOfBoardIdentifier></xbrldi:typedMember></scenario></context><!--BOARD6--><context id="c52"><entity><identifier scheme="http://www.dcca.dk/cvr">32266355</identifier></entity><period><startDate>2014-07-01</startDate><endDate>2015-06-30</endDate></period><scenario><xbrldi:typedMember dimension="d:IdentificationOfMemberOfSupervisoryBoardDimension"><d:memberOfBoardIdentifier>6</d:memberOfBoardIdentifier></xbrldi:typedMember></scenario></context><!--BOARD7--><context id="c53"><entity><identifier scheme="http://www.dcca.dk/cvr">32266355</identifier></entity><period><startDate>2014-07-01</startDate><endDate>2015-06-30</endDate></period><scenario><xbrldi:typedMember dimension="d:IdentificationOfMemberOfSupervisoryBoardDimension"><d:memberOfBoardIdentifier>7</d:memberOfBoardIdentifier></xbrldi:typedMember></scenario></context><!--BOARD8--><context id="c54"><entity><identifier scheme="http://www.dcca.dk/cvr">32266355</identifier></entity><period><startDate>2014-07-01</startDate><endDate>2015-06-30</endDate></period><scenario><xbrldi:typedMember dimension="d:IdentificationOfMemberOfSupervisoryBoardDimension"><d:memberOfBoardIdentifier>8</d:memberOfBoardIdentifier></xbrldi:typedMember></scenario></context><!--CEO1--><context id="c71"><entity><identifier scheme="http://www.dcca.dk/cvr">32266355</identifier></entity><period><startDate>2014-07-01</startDate><endDate>2015-06-30</endDate></period><scenario><xbrldi:typedMember dimension="d:IdentificationOfMemberOfExecutiveBoardDimension"><d:memberOfBoardIdentifier>1</d:memberOfBoardIdentifier></xbrldi:typedMember></scenario></context><!--REVISOR1--><context id="c88"><entity><identifier scheme="http://www.dcca.dk/cvr">32266355</identifier></entity><period><startDate>2014-07-01</startDate><endDate>2015-06-30</endDate></period><scenario><xbrldi:typedMember dimension="d:IdentificationOfAuditorDimension"><d:auditorIdentifier>1</d:auditorIdentifier></xbrldi:typedMember></scenario></context><!--Overfoert resultat aktuel i aaret--><context id="c122"><entity><identifier scheme="http://www.dcca.dk/cvr">32266355</identifier></entity><period><startDate>2014-07-01</startDate><endDate>2015-06-30</endDate></period><scenario><xbrldi:explicitMember dimension="e:ResultDistributionDimension">e:RetainedEarningsMember</xbrldi:explicitMember></scenario></context><!--Overfoert resultat forrige i aaret--><context id="c123"><entity><identifier scheme="http://www.dcca.dk/cvr">32266355</identifier></entity><period><startDate>2013-07-01</startDate><endDate>2014-06-30</endDate></period><scenario><xbrldi:explicitMember dimension="e:ResultDistributionDimension">e:RetainedEarningsMember</xbrldi:explicitMember></scenario></context><!--Andre anlag aktuel primo--><context id="c160"><entity><identifier scheme="http://www.dcca.dk/cvr">32266355</identifier></entity><period><instant>2014-07-01</instant></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfPropertyPlantAndEquipmentDimension">e:FixturesFittingsToolsAndEquipmentMember</xbrldi:explicitMember></scenario></context><!--Andre anlag aktuel i aaret--><context id="c161"><entity><identifier scheme="http://www.dcca.dk/cvr">32266355</identifier></entity><period><startDate>2014-07-01</startDate><endDate>2015-06-30</endDate></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfPropertyPlantAndEquipmentDimension">e:FixturesFittingsToolsAndEquipmentMember</xbrldi:explicitMember></scenario></context><!--Andre anlag aktuel ultimo--><context id="c162"><entity><identifier scheme="http://www.dcca.dk/cvr">32266355</identifier></entity><period><instant>2015-06-30</instant></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfPropertyPlantAndEquipmentDimension">e:FixturesFittingsToolsAndEquipmentMember</xbrldi:explicitMember></scenario></context><!--Virksomhedskapital aktuel primo--><context id="c181"><entity><identifier scheme="http://www.dcca.dk/cvr">32266355</identifier></entity><period><instant>2014-07-01</instant></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:ContributedCapitalMember</xbrldi:explicitMember></scenario></context><!--Virksomhedskapital aktuel ultimo--><context id="c183"><entity><identifier scheme="http://www.dcca.dk/cvr">32266355</identifier></entity><period><instant>2015-06-30</instant></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:ContributedCapitalMember</xbrldi:explicitMember></scenario></context><!--Overkurs emission aktuel i aaret--><context id="c185"><entity><identifier scheme="http://www.dcca.dk/cvr">32266355</identifier></entity><period><startDate>2014-07-01</startDate><endDate>2015-06-30</endDate></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:SharePremiumMember</xbrldi:explicitMember></scenario></context><!--Overfort res aktuel primo--><context id="c199"><entity><identifier scheme="http://www.dcca.dk/cvr">32266355</identifier></entity><period><instant>2014-07-01</instant></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:RetainedEarningsMember</xbrldi:explicitMember></scenario></context><!--Overfort res aktuel i aaret--><context id="c200"><entity><identifier scheme="http://www.dcca.dk/cvr">32266355</identifier></entity><period><startDate>2014-07-01</startDate><endDate>2015-06-30</endDate></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:RetainedEarningsMember</xbrldi:explicitMember></scenario></context><!--Overfort res aktuel ultimo--><context id="c201"><entity><identifier scheme="http://www.dcca.dk/cvr">32266355</identifier></entity><period><instant>2015-06-30</instant></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:RetainedEarningsMember</xbrldi:explicitMember></scenario></context><!--HTAL aar3--><context id="c261"><entity><identifier scheme="http://www.dcca.dk/cvr">32266355</identifier></entity><period><startDate>2014-07-01</startDate><endDate>2015-06-30</endDate></period><scenario><xbrldi:explicitMember dimension="d:RetrospectiveInformationDimension">d:TwoYearsAgoMember</xbrldi:explicitMember></scenario></context><!--HTAL ultimo aar3--><context id="c263"><entity><identifier scheme="http://www.dcca.dk/cvr">32266355</identifier></entity><period><instant>2015-06-30</instant></period><scenario><xbrldi:explicitMember dimension="d:RetrospectiveInformationDimension">d:TwoYearsAgoMember</xbrldi:explicitMember></scenario></context><!--HTAL aar4--><context id="c264"><entity><identifier scheme="http://www.dcca.dk/cvr">32266355</identifier></entity><period><startDate>2014-07-01</startDate><endDate>2015-06-30</endDate></period><scenario><xbrldi:explicitMember dimension="d:RetrospectiveInformationDimension">d:ThreeYearsAgoMember</xbrldi:explicitMember></scenario></context><!--HTAL ultimo aar4--><context id="c266"><entity><identifier scheme="http://www.dcca.dk/cvr">32266355</identifier></entity><period><instant>2015-06-30</instant></period><scenario><xbrldi:explicitMember dimension="d:RetrospectiveInformationDimension">d:ThreeYearsAgoMember</xbrldi:explicitMember></scenario></context><!--HTAL aar5--><context id="c267"><entity><identifier scheme="http://www.dcca.dk/cvr">32266355</identifier></entity><period><startDate>2014-07-01</startDate><endDate>2015-06-30</endDate></period><scenario><xbrldi:explicitMember dimension="d:RetrospectiveInformationDimension">d:FourYearsAgoMember</xbrldi:explicitMember></scenario></context><!--HTAL ultimo aar5--><context id="c269"><entity><identifier scheme="http://www.dcca.dk/cvr">32266355</identifier></entity><period><instant>2015-06-30</instant></period><scenario><xbrldi:explicitMember dimension="d:RetrospectiveInformationDimension">d:FourYearsAgoMember</xbrldi:explicitMember></scenario></context><!--Virksomhedskapital forrige EKprimo--><context id="c720"><entity><identifier scheme="http://www.dcca.dk/cvr">32266355</identifier></entity><period><instant>2013-07-01</instant></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:ContributedCapitalMember</xbrldi:explicitMember></scenario></context><!--Virksomhedskapital forrige EKultimo--><context id="c722"><entity><identifier scheme="http://www.dcca.dk/cvr">32266355</identifier></entity><period><instant>2014-06-30</instant></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:ContributedCapitalMember</xbrldi:explicitMember></scenario></context><!--Overkurs emission forrige EKi aaret--><context id="c727"><entity><identifier scheme="http://www.dcca.dk/cvr">32266355</identifier></entity><period><startDate>2013-07-01</startDate><endDate>2014-06-30</endDate></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:SharePremiumMember</xbrldi:explicitMember></scenario></context><!--Overfort res forrige EKprimo--><context id="c741"><entity><identifier scheme="http://www.dcca.dk/cvr">32266355</identifier></entity><period><instant>2013-07-01</instant></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:RetainedEarningsMember</xbrldi:explicitMember></scenario></context><!--Overfort res forrige EKi aaret--><context id="c742"><entity><identifier scheme="http://www.dcca.dk/cvr">32266355</identifier></entity><period><startDate>2013-07-01</startDate><endDate>2014-06-30</endDate></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:RetainedEarningsMember</xbrldi:explicitMember></scenario></context><!--Overfort res forrige EKultimo--><context id="c743"><entity><identifier scheme="http://www.dcca.dk/cvr">32266355</identifier></entity><period><instant>2014-06-30</instant></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:RetainedEarningsMember</xbrldi:explicitMember></scenario></context><!--DKK enere--><unit id="u5"><measure>iso4217:DKK</measure></unit></xbrl>